Intas Pharmaceuticals Limited Temozolomide Export Data — India (DGFT 2022–2026)

Name: Intas Pharmaceuticals Limited Temozolomide Export Records India — #5 Exporter, 49 Shipments, $825.2K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Temozolomide

India Pharmaceutical Trade Intelligence

$23.5M133 Suppliers90 CountriesHS 30049049

ExportsIndia → CANADA31.8%India → BELGIUM22.5%

ImportsBELGIUM → India$34.4K NETHERLANDS → India$30.5K

#1 Supplier: SUN PHARMACEUTICAL #1 Buyer: YUSEN LOGISTICS

Intas Pharmaceuticals Limited — Temozolomide Exporter #5 | $825.2K Trade Value | TransData Nexus | TransData Nexus

Intas Pharmaceuticals Limited — Temozolomide Exporter Profile

Indian Pharmaceutical Exporter · #5 for Temozolomide · $825.2K export value · DGFT Verified

Intas Pharmaceuticals Limited is the #5 Indian exporter of Temozolomide with $825.2K in export value and 49 verified shipments. Intas Pharmaceuticals Limited holds a 3.5% market share in Temozolomide exports across 9 countries. The company exports 75 pharmaceutical products worth $372.3M across 19 therapeutic categories.

Intas Pharmaceuticals Limited — Temozolomide Export Profile: Buyers & Destinations

Intas Pharmaceuticals Limited Temozolomide export treemap — buyers and destination countries | TransData Nexus

Where Does Intas Pharmaceuticals Limited Export Temozolomide?

Country	Value	Shipments	Share
POLAND	$178.7K	7	18.9%
NETHERLANDS	$175.8K	8	18.6%
UNITED STATES	$145.2K	23	15.3%
FRANCE	$141.2K	3	14.9%
THAILAND	$131.0K	3

Who Are the Top Buyers of Temozolomide from Intas Pharmaceuticals Limited?

Buyer	Country	Value	Orders
ALLIANCE PHARMA CO., LTD.	THAILAND	$131.0K	3
EVERSANA LIFE SCIENCES SERVICES,LLC	UNITED STATES	$130.9K	22
ACCORD HEALTHCARE B V	NETHERLANDS	$118.4K	5
XXCORXXHEAXXHCAXX POXXKA XX ZXX O	POLAND	$115.9K	3
XXCORXXHEAXXHCAXX B XX	FRANCE	$114.2K	6
XXCORXXHEAXXHCAXX SXX	ITALY	$97.8K	5
XXCORXXNL XX XXB	FRANCE	$96.3K	2
ACCORD HEALTHCARE POLSKA SP Z O O	POLAND	$62.8K	4
ACCORD HEALTHCARE PTY LTD	SOUTH AFRICA	$46.9K	2
ACCORD HEALTHCARE SLU	SPAIN	$16.1K	3

Intas Pharmaceuticals Limited supplies Temozolomide to 14 buyers globally. The largest buyer is ALLIANCE PHARMA CO., LTD. (THAILAND), followed by EVERSANA LIFE SCIENCES SERVICES,LLC (UNITED STATES) and ACCORD HEALTHCARE B V (NETHERLANDS). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Temozolomide Formulations Does Intas Pharmaceuticals Limited Export?

Product Description / Formulation	Value	Shipments
TEMOZOLOMIDE ACCORD 140MG	$142.3K	4
TEMOZOLOMIDE ACCORD 20	$93.2K	8
TEMOZOLOMIDE ACCORD 140 MG	$83.5K	2
TEMOZOLOMIDE ACCORD 140	$50.0K	1
PH.DRU.& MED.: ZOLOTEM 250MG CAPSULES (EACH HARD GELATIN CAPSULES CONTAINS: TEMOZOLOMIDE 250MG) [1X5C PER PACK]	$50.0K	1
PH.DRU.& MED.: ZOLOTEM 100MG CAPSULES (EACH HARD GELATIN CAPSULES CONTAINS: TEMOZOLOMIDE 100MG) [1X5C PER PACK]	$50.0K	1
PHA.DRU & MEDI, TEMOZOL USP -100MG-5C-AMBER(US-ACCO EACH HARD GELATIN CAPSULE CONTAINS TEMOZOLOMIDE 100 MG 11912X1X5CNOS	$49.0K	3
TEMOZOLOMIDE ACCORD 180MG	$46.3K	1
TEMOZOLOMIDEACCORD 5MG	$45.0K	1
TEMOZOLOMIDE ACCORD 100MG	$41.5K	1

Intas Pharmaceuticals Limited exports 25 distinct Temozolomide formulations including tablets, capsules, syrups, and combination drugs. The top formulation is TEMOZOLOMIDE ACCORD 140MG with 4 shipments worth $142.3K.

How Does Intas Pharmaceuticals Limited Compare to Nearest Temozolomide Exporters?

Exporters ranked immediately above and below #5 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
4	RELIANCE LIFE SCIENCES PRIVATE LIMITED	$1.7M	100	14	$16.7K
2	SUN PHARMACEUTICAL INDUSTRIES LTD	$950.0K	19	4	$50.0K
5	INTAS PHARMACEUTICALS LIMITED ★	$825.2K	49	9	$16.8K
6	ACCURE LABS PRIVATE LIMITED	$631.0K	45	1	$14.0K
7	INTAS PHARMACEUTICALS LTD	$500.0K	10	6	$50.0K

Intas Pharmaceuticals Limited ranks #5 among 133 Indian Temozolomide exporters. Average shipment value of $16.8K compared to the market average of $163.4K. The closest competitors by value are RELIANCE LIFE SCIENCES PRIVATE LIMITED and SUN PHARMACEUTICAL INDUSTRIES LTD.

Which Indian Ports Ship Temozolomide Exports?

Port	Shipments	% Share
SAHAR AIR CARGO ACC (INBOM4)	247	19.6%
SAHAR AIR	221	17.5%
NHAVA SHEVA SEA (INNSA1)	112	8.9%
DELHI AIR CARGO ACC (INDEL4)	99	7.9%
DELHI AIR	72	5.7%
JNPT/ NHAVA SHEVA SEA	53	4.2%
Bombay Air	51	4.0%
HYDERABAD ACC (INHYD4)	50	4.0%

Geopolitical & Trade Policy Impact on Intas Pharmaceuticals Limited's Temozolomide Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Intas Pharmaceuticals. The Israel-Iran tensions have led to increased security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor, prompting major carriers to reroute shipments around the Cape of Good Hope. This detour has extended transit times by 10–20 days and raised freight rates by 40–50% on key India–Europe routes, impacting the cost-effectiveness and timeliness of exports. (livemint.com)

Conversely, the ongoing US-China trade tensions have opened avenues for Indian pharmaceutical companies to capture a larger share of the U.S. market. Intas's acquisition of UDENYCA® and the FDA's acceptance of its biosimilar applications position the company to leverage these opportunities effectively. However, compliance with the European Union's Falsified Medicines Directive (FMD) remains a critical factor for market access. Intas's proactive approach in securing partnerships and ensuring regulatory compliance underscores its commitment to maintaining and expanding its presence in the European market.

Intas Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

Maintaining stringent regulatory compliance is paramount for Indian pharmaceutical exporters. Intas Pharmaceuticals has demonstrated a strong commitment to adhering to international quality standards, as evidenced by its successful acquisitions and partnerships that necessitate compliance with FDA, WHO, and EU Good Manufacturing Practices (GMP). The company's proactive engagement in regulatory processes, such as the FDA's acceptance of its Biologics License Application for DMB-3115, reflects its dedication to quality and compliance. (intaspharma.com) As global regulatory requirements continue to evolve, Intas's focus on quality assurance and compliance positions it favorably in the competitive pharmaceutical export market.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Temozolomide shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Intas Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 59 individual customs records matching Intas Pharmaceuticals Limited exporting Temozolomide, covering 25 formulations to 10 countries via 14 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 90+ countries, 250+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Temozolomide

Temozolomide

Intas Pharmaceuticals Limited — Temozolomide Exporter Profile

Intas Pharmaceuticals Limited — Temozolomide Export Profile: Buyers & Destinations

Where Does Intas Pharmaceuticals Limited Export Temozolomide?

Who Are the Top Buyers of Temozolomide from Intas Pharmaceuticals Limited?

What Is India's Total Temozolomide Export Value and How Much Does Intas Pharmaceuticals Limited Contribute?

What Is the Average Shipment Value for Intas Pharmaceuticals Limited's Temozolomide Exports?

How Does Intas Pharmaceuticals Limited Compare to Other Indian Temozolomide Exporters?

What Temozolomide Formulations Does Intas Pharmaceuticals Limited Export?

Regulatory Requirements: Exporting Temozolomide to Key Markets

United States — FDA

How Does Intas Pharmaceuticals Limited Compare to Nearest Temozolomide Exporters?

Which Indian Ports Ship Temozolomide Exports?

Geopolitical & Trade Policy Impact on Intas Pharmaceuticals Limited's Temozolomide Exports

Intas Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

About Intas Pharmaceuticals Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Temozolomide Export Data from Intas Pharmaceuticals Limited

Temozolomide Stats

Company Overview

Top Products by Intas Pharmaceuticals Limited

Related Analysis

Need Detailed Export Data?

Data Source